Tempus AITEM +6.85%35 EBITDA Margin % is -23.66% as of Mar. 2026. GuruFocus rates TEM with a GF Score™ of 35/100. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Tempus AI ranks worse than 80.99% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tempus AI's EBITDA for the
three
months ended in Mar. 2026 was $-82 Mil. Tempus AI's Revenue for the
three
months ended in Mar. 2026 was $348 Mil. Therefore, Tempus AI's EBITDA margin for the quarter that ended in Mar. 2026 was -23.66%.
Tempus AI (NAS:TEM) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tempus AI EBITDA Margin % Related Terms
Tempus AI EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Tempus AI's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TEM vs HQY, BTSG, HNGE: EBITDA Margin % Comparison
For the Health Information Services subindustry, Tempus AI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tempus AI EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tempus AI's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tempus AI's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tempus AI (TEM) has a EBITDA Margin % of -23.66% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tempus AI and its competitors. According to the industry distribution chart, Tempus AI ranks #541 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 81%.
Is Tempus AI's EBITDA Margin % too high?
Tempus AI's current EBITDA Margin % is -23.66%. Based on the distribution chart, Tempus AI ranks #541 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tempus AI has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Tempus AI's EBITDA Margin % compare to HQY and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Tempus AI ranks #541 out of 668 companies for EBITDA Margin %. This places Tempus AI in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tempus AI and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tempus AI's current EBITDA Margin % is -23.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tempus AI stock overvalued right now?
Tempus AI (TEM) has a current EBITDA Margin % of -23.66%. The current EBITDA Margin % is -23.66%. Tempus AI's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tempus AI (TEM), the current EBITDA Margin % is -23.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
35GF Score
Get the complete analysis for TEM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TEM has been successfully added to your 
